Supply Chain Finance by Industry: Who Is Using It, Who Should Be, and Why It Matters for Pharma and Aerospace
June 16, 2026

June 16, 2026

A decade ago, Supply Chain Finance (SCF) was predominantly associated with a narrow set of industries: automotive, retail, and consumer goods. These were sectors with large, centralized buyers and extensive supplier networks that made program implementation economically attractive.
Today, that picture has changed substantially. Supplier Financing has expanded into chemicals, pharmaceuticals, agriculture, mining, oil and gas, utilities, food and beverage, services, and even airlines. The common thread is not industry type, it is working capital pressure, complex supplier relationships, and the need to optimize liquidity across the supply chain.
Based on analysis of current SCF program implementations across North America and Europe, industry penetration rates (as a share of eligible companies with active SCF programs) are approximately:
The pharmaceutical sector represents one of the most compelling and underserved SCF opportunities. With penetration at approximately 20%, pharma lags well behind retail and automotive, but the structural case for expansion is strong.
Pharmaceutical supply chains are among the most complex in global trade. They involve specialized raw materials, active pharmaceutical ingredients sourced globally, contract manufacturers across multiple geographies, and regulatory requirements that add time and cost to every transaction. This complexity creates significant working capital pressure, particularly in the supplier base.
At the same time, large multinational drugmakers typically carry investment-grade credit ratings, making them ideal anchors for Approved Payables Finance programs. The combination of strong buyer credit and cash-constrained suppliers creates exactly the conditions where SCF delivers maximum value.
Payment terms in pharma have also lengthened significantly in recent years, as large buyers seek to optimize their working capital positions. This creates a real need for supplier financing, and a real opportunity for platforms that can provide both the benchmarking intelligence to understand where terms stand and the financing mechanisms to ensure suppliers are not harmed by extended terms.
Aerospace penetration is estimated at 8% of eligible spend, significantly below the sector's potential. The sector presents unique characteristics:
These characteristics make aerospace an ideal candidate for Approved Payables Finance specifically, where the buyer's irrevocable payment guarantee provides the credit anchor that allows specialized, smaller suppliers to access financing at rates they could not obtain independently. The cost of a supplier failure in aerospace (in terms of production disruption and replacement lead times) makes protecting supplier financial health economically rational for OEMs.
PE-backed companies represent a distinct and growing segment for Supply Chain Finance. Private equity firms have become increasingly sophisticated in their approach to working capital management, recognizing that payment terms optimization and SCF implementation can deliver significant returns during the holding period.
A PE-backed portfolio company that improves DPO by 15 days and implements a Supply Chain Finance program can unlock meaningful liquidity, without requiring equity injection or external debt. This liquidity can be used to fund bolt-on acquisitions, reduce leverage, or support operational investments.
For PE sponsors, the working capital opportunity is often quantifiable from day one, and platforms that provide the benchmarking data to identify and execute on that opportunity quickly have particular relevance in this market.
SCF penetration is not evenly distributed geographically. North America represents approximately 53% of global SCF outstanding, Europe 30%, Latin America 9%, Asia-Pacific 5%, and the Middle East and Africa 2%.
Asia is the fastest-growing region, SCF volume grew 40-50% in the region in recent years, driven by working capital pressures among Asian suppliers and increasing adoption by local corporates as anchor buyers. The challenge in Asia is regulatory fragmentation, language barriers, and country-specific funding restrictions.
Europe is growing steadily, driven in part by the EU payment directive limiting commercial transaction payment terms to 60 days, which has created demand for SCF as a tool to support suppliers who need early payment within these constraints.
Retail (60% penetration), automotive (50%), and telecommunications (50%) are the leading sectors for Supply Chain Finance adoption in North America and Europe. These sectors have large, concentrated buying organizations with extensive supplier networks, making SCF programs economically attractive. Food and beverage (40%) and manufacturing (30%) are also significant. Pharma (20%), oil and gas (20%), and commodities/mining (10%) have lower penetration but significant untapped potential.
Pharma companies typically carry investment-grade credit ratings, making them ideal anchors for SCF programs. Their supply chains are complex and global, with many cash-constrained specialized suppliers who benefit significantly from early payment access. Payment terms have also extended in recent years, increasing the working capital pressure on pharma suppliers and the value that SCF can provide.
Aerospace supply chains involve highly specialized, often small-to-medium suppliers for critical components. A supplier failure, caused by financial stress from extended payment terms, can have severe production consequences for OEMs. Approved Payables Finance protects strategic aerospace suppliers by providing access to financing at rates anchored to the buyer's credit rating, not the supplier's. This protects supply chain continuity while also improving the buyer's working capital position.
Asia is the fastest-growing region for Supply Chain Finance, with annual growth of 40-50% in recent years. The Middle East and Africa are also emerging SCF markets. Europe is growing at approximately 40% between certain periods (notably a 43% growth rate between 2011 and 2013 for some measures). North America, while the largest market by outstanding volume, shows more moderate growth as the market matures.